CCL
82
-2
TEL
50
-5
SCHW
50
-2
MRO
62
10
PPL
59
5
HPE
50
-9
PFG
37
-3
NDAQ
52
-4
MS
68
-4
USB
48
-5
LNC
69
4
SWKS
33
-3
A
34
-2
SYK
51
-9
PNW
66
2
EFX
35
-3
AAL
42
-8
MAR
57
-6
ETN
67
-6
PHM
55
-2
CCL
82
-2
TEL
50
-5
SCHW
50
-2
MRO
62
10
PPL
59
5
HPE
50
-9
PFG
37
-3
NDAQ
52
-4
MS
68
-4
USB
48
-5
LNC
69
4
SWKS
33
-3
A
34
-2
SYK
51
-9
PNW
66
2
EFX
35
-3
AAL
42
-8
MAR
57
-6
ETN
67
-6
PHM
55
-2
Financhill
Back

Nuveen New York AMT-Free Quality Municipal Income Fund Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
30

NRK
Nuveen New York AMT-Free Quality Municipal Income Fund

Last Price:
10.87
Seasonality Move:
2.37%
Buy
71

MDGL
Madrigal Pharmaceuticals

Last Price:
259.70
Seasonality Move:
31.67%
Sell
30
Nuveen New York AMT-Free Quality Municipal Income Fund (NRK) is a Sell

Is Nuveen New York AMT-Free Quality Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen New York AMT-Free Quality Municipal Income Fund [NRK] share price is $10.87. The Score for NRK is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NRK Stock Price Chart

What is Nuveen New York AMT-Free Quality Municipal Income Fund's stock price today?

  • The Nuveen New York AMT-Free Quality Municipal Income Fund share price today is $10.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRK is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $259.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

NRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 38.15 Sell
Chaikin Money Flow: 131283 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 11.21) Sell
Bollinger Bands (100): (10.96 - 11.18) Sell

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 74.74 Buy
Chaikin Money Flow: 898979 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (203.29 - 223.91) Buy
Bollinger Bands (100): (221.8 - 277.54) Buy

NRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.84 Buy
20-day SMA: 11 Sell
50-day SMA: 11.11 Sell
200-day SMA: 10.93 Sell
8-day EMA: 10.86 Buy
20-day EMA: 10.97 Sell
50-day EMA: 11.05 Sell
200-day EMA: 10.88 Sell

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 216.22 Buy
20-day SMA: 214.16 Buy
50-day SMA: 227.04 Buy
200-day SMA: 240.71 Buy
8-day EMA: 223.2 Buy
20-day EMA: 218.42 Buy
50-day EMA: 226.38 Buy
200-day EMA: 233.63 Buy

Nuveen New York AMT-Free Quality Municipal Income Fund Earnings Growth & NRK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.

Nuveen New York AMT-Free Quality Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):